ಹಾವು ಕಡಿತಕ್ಕೆ ನೂತನ ಚಿಕಿತ್ಸಾ ಕ್ರಮ ಕಂಡುಹಿಡಿದ ಹುಬ್ಬಳ್ಳಿ ಕೆಎಂಸಿಆರ್​​ಐ ವೈದ್ಯರು: ಇದು ದೇಶದಲ್ಲೇ ಪ್ರಥಮ ಅಧ್ಯಯನ

ETVBHARAT

ಹುಬ್ಬಳ್ಳಿ ಕೆಎಂಸಿಆರ್​ಐ ವೈದ್ಯರು ಹಾವು ಕಡಿತಕ್ಕೆ ಹೊಸ ಚಿಕಿತ್ಸಾ ವಿಧಾನ ಕಂಡುಹಿಡಿದಿದ್ದಾರೆ. ಈ ಸಂಶೋಧನೆ ದೇಶದಲ್ಲಿಯೇ ಮೊದಲು ನಡೆದಿದೆ ಎಂಬ ಹೆಗ್ಗಳಿಕೆಗೆ ಭಾಜನವಾಗಿದೆ.

Transcript

00:00When we were able to do clinical features, we were able to treat clinical features.

00:17That is why they have to use the ankle features, the weakness, the bleeding.

00:25That is why we have to use the ASM.

00:30These are all standard practices.

00:32That is why we have to use it.

00:34We have to use a marker.

00:38We have to use the ASM to use.

00:53The ASM is very valuable.

00:56If we have to use the ASM, we can use the ASM to use it.

00:59We can use the ASM to use the ASM to use it.

01:04In this case, we have a market.

01:08If we go to the market, we can go to the market.

01:11If we go to the market, we can go to the market.

01:14We can go to the market and go to the market.

01:17So, we have a market.

01:21We can go to the market.

01:24We have 5' nucleotidease and 1' glyphosatease.

01:29We have a lot of these.

01:33We have to go to the market.

01:36It is a Swami.

01:38We have two-party sellers.

01:40You know, there are three careers.

01:42I have to have a lot of people here.

01:45You know, there are a lot of people.

01:48Some are all toxic.

01:49Some are all toxic.

01:52Some are all toxic.

01:54Some are bleeding.

01:55Some are vipers.

01:57Some are russle vipers,

02:00It is the same as the same component.

02:05The hospital is the same as the pipe ride nucleotides.

02:09What is the case?

02:11The patient is coming to the hospital.

02:14If the patient is coming to the hospital or emergency,

02:17the patient is coming to the hospital.

02:20The treatment is the same as the patient is coming to the hospital.

02:25What is the patient's treatment?

02:35The patient's treatment is a standard protocol.

02:50If you have a bad age, you can see ASV is bad.

02:55You can see ASV is bad and not in the same place.

03:01These are observations.

03:03If you have three things, these are the 5' nucleotides.

03:14In the case of our eyes, these 5-prime nucleotides have severe physical pictures, bleeding,

03:23skin swelling, or ulcerative scars, or weakness.

03:30In that case, these 2-levels, enzyme levels, 5-prime nucleotides are very good.

03:39There are no features of Kelopur.

03:44There are no levels of level.

03:48There are no physical features of Kelopur.

03:53There are no serious problems.

03:58There are no levels of level.

04:01There are no levels of level.

04:04This is the first part.

04:10We have a marker.

04:14We have five times recruited.

04:18We have a advantage because we have a severity.

04:24We have a severity.

04:28If you see the severity, it changes the complications of the GI.

04:32If you see the complication or the GI level, it is not very complex.

04:41If you start the AC level your regular pluses immediately,

04:46if you take a few minute now,

04:49if you think of the patient that might not be noticed,

04:52it might not be noticed,

04:53if you think of that any other pictures.

04:55So, if you test the level of the test, you can discharge the level of the test.

05:01If patients say, if they don't know what we are going to do with the test,

05:08if they don't know what we are going to do with the treatment,

05:12then they can discharge the levels.

05:17If we are interested, we are interested in the observation and the complication of the ESP level.

05:31That's why we are interested in this idea.

05:34If we are a multi-centric study, we have a recommendation for this idea.

05:42This is the first time.

05:44No one can't do anything in this situation.

05:49We can't change the treatment protocol.

05:52That's why we can't do it.

05:54We can't do it.

05:55We can't do it.

05:57We can't identify the ASV and identify the ASV.

06:01We can't do it.

06:06We can't do it.

06:10We can't do it.

06:12We can't do it.

06:15If we don't have any problems with the ASV,

06:19then we can't do it.

06:22We can't do it.

06:26We can't do it.

06:29We can't do it.

06:33We can't do it.

06:35We can't do it.

06:37We can't do it.

06:41I can't do it.

06:46Like, you have to test we can't do it.

06:48But we can't do it.

06:50And we can't do it.

06:51We can't do it.

06:52snelS, that's the data alert.

06:57It is the same as the bleeding, bleeding and pressure.

07:02There are no risks that exercise.

07:05It doesn't mean that we are doing it for the pain,

07:06that thing is not Umu.

07:08That thing is we can test it.

07:13But if we do that, we are going to test it routinely.

07:19We will test it routinely.

07:26If you have a test, you can use it as a standard.

07:29If you have one extra test, you can use it.

07:32You can use it correctly.

07:35If you have a sign, you can use it as a treatment.

07:39You can use it as a normal level.

ಹಾವು ಕಡಿತಕ್ಕೆ ನೂತನ ಚಿಕಿತ್ಸಾ ಕ್ರಮ ಕಂಡುಹಿಡಿದ ಹುಬ್ಬಳ್ಳಿ ಕೆಎಂಸಿಆರ್ಐ ವೈದ್ಯರು: ಇದು ದೇಶದಲ್ಲೇ ಪ್ರಥಮ ಅಧ್ಯಯನ

Category

Transcript

Recommended

Category

Transcript

Recommended

ಹಾವು ಕಡಿತಕ್ಕೆ ನೂತನ ಚಿಕಿತ್ಸಾ ಕ್ರಮ ಕಂಡುಹಿಡಿದ ಹುಬ್ಬಳ್ಳಿ ಕೆಎಂಸಿಆರ್ಐ ವೈದ್ಯರು: ಇದು ದೇಶದಲ್ಲೇ ಪ್ರಥಮ ಅಧ್ಯಯನ